Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 101

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 101
---
 the Plan

(a) .
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.

(b) . Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Common Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Common Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options
or base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise
Price or base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel
outstanding Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for
cash or other securities.

(c) . The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.

(d) . A termination or amendment of the Plan that occurs after an Award is made shall not materially
impair the rights of a Participant unless the Participant consents or unless the Committee acts under Section 18(f) below.
The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Award. Whether or
not the Plan has terminated, an outstanding Award may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan, provided that the Participant’s consent is not required
if any termination or amendment to the Participant’s outstanding Award does not materially impair the rights or materially increase
the obligations of the Participant.

Section 18. Miscellaneous

(a) . Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Awards under the Plan in connection with the acquisition,